Psychological and pharmacological interventions for depression in patients with diabetes mellitus and depression (Q24202387)

Cochrane Database of Systematic Reviews

Europe PubMed Central

title

Psychological and pharmacological interventions for depression in patients with diabetes mellitus and depression (English)

0 references

0 references

1 reference

3

Jürgen Bengel

0 references

author name string

Harald Baumeister

series ordinal

1

0 references

Nico Hutter

series ordinal

2

0 references

publication date

12 December 2012

0 references

published in

0 references

cites work

Disparities by education level in outcomes of a self-management intervention: the DELTA trial in The Netherlands.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Economic evaluation of a minimal psychological intervention in chronically ill elderly patients with minor or mild to moderate depression: a randomized trial (the DELTA-study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Effectiveness and cost-effectiveness of a minimal psychological intervention to reduce non-severe depression in chronically ill elderly patients: the design of a randomised controlled trial [ISRCTN92331982]

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

A minimal psychological intervention in chronically ill elderly patients with depression: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Treating depression in diabetes patients: does a nurse-administered minimal psychological intervention affect diabetes-specific quality of life and glycaemic control? A randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Effect of pharmacological treatment of depression on A1C and quality of life in low-income Hispanics and African Americans with diabetes: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Comparison of fluoxetine and paroxetine in type II diabetes mellitus patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Quality of life and metabolic status in mildly depressed women with type 2 diabetes treated with paroxetine: A single-blind randomised placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Quality of life and metabolic status in mildly depressed patients with type 2 diabetes treated with paroxetine: a double-blind randomised placebo controlled 6-month trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

A randomized trial of telephonic counseling plus walking for depressed diabetes patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Development and reach of a web-based cognitive behavioural therapy programme to reduce symptoms of depression and diabetes-specific distress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Web-based depression treatment for type 1 and type 2 diabetic patients: a randomized, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Web-based cognitive behavioural therapy (W-CBT) for diabetes patients with co-morbid depression: design of a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Online cognitieve gedragstherapie voor diabetespatiënten met depressieve klachten: een gerandomiseerd gecontroleerd onderzoek

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Safety and efficacy of s-citalopram in patients with co-morbid major depression and diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Integrating type 2 diabetes mellitus and depression treatment among African Americans: a randomized controlled pilot trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Predictors of incident major depression in diabetic outpatients with subthreshold depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Depression and diabetes among low-income Hispanics: design elements of a socioculturally adapted collaborative care model randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Collaborative care management of major depression among low-income, predominantly Hispanic subjects with diabetes: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

One-year postcollaborative depression care trial outcomes among predominantly Hispanic diabetes safety net patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

The impact of blood glucose monitoring on depression and distress in insulin-naïve patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Cost-effectiveness of collaborative care for chronically ill patients with comorbid depressive disorder in the general hospital setting, a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

The effectiveness of depression care management on diabetes-related outcomes in older patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Efficacy of sertraline in prevention of depression recurrence in older versus younger adults with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Integrating depression and chronic disease care among patients with diabetes and/or coronary heart disease: the design of the TEAMcare study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Collaborative care for patients with depression and chronic illnesses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

TEAMcare: an integrated multicondition collaborative care program for chronic illnesses and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Sertraline for prevention of depression recurrence in diabetes mellitus: a randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Long-term effects on medical costs of improving depression outcomes in patients with depression and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

The Pathways Study: a randomized trial of collaborative care in patients with diabetes and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Improving primary care treatment of depression among patients with diabetes mellitus: the design of the pathways study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Improving depression care in patients with diabetes and multiple complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Effects of enhanced depression treatment on diabetes self-care

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Supplementation with eicosapentaenoic omega-3 fatty acid does not influence serum brain-derived neurotrophic factor in diabetes mellitus patients with major depression: a randomized controlled pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Eicosapentaenoic acid as an add-on to antidepressant medication for co-morbid major depression in patients with diabetes mellitus: a randomized, double-blind placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Limited effect of screening for depression with written feedback in outpatients with diabetes mellitus: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Diabetes, depression, and death: a randomized controlled trial of a depression treatment program for older adults based in primary care (PROSPECT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Disease management for co-morbid depression and anxiety in diabetes mellitus: design of a randomised controlled trial in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

The TrueBlue study: is practice nurse-led collaborative care effective in the management of depression for patients with heart disease or diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Short-term effects of cognitive behavioural group training (CBGT) in adult Type 1 diabetes patients in prolonged poor glycaemic control. A randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Testing the effectiveness of a mindfulness-based intervention to reduce emotional distress in outpatients with diabetes (DiaMind): design of a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Within-trial economic evaluation of diabetes-specific cognitive behaviour therapy in patients with type 2 diabetes and subthreshold depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Cost-effectiveness analysis of cognitive behaviour therapy for treatment of minor or mild-major depression in elderly patients with type 2 diabetes: study protocol for the economic evaluation alongside the MIND-DIA randomized controlled trial (MIND-

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Cognitive behavioural therapy in elderly type 2 diabetes patients with minor depression or mild major depression: study protocol of a randomized controlled trial (MIND-DIA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Psychoeducation versus treatment as usual in diabetic patients with subthreshold depression: preliminary results of a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Does treatment of subsyndromal depression improve depression and diabetes related outcomes: protocol for a randomised controlled comparison of psycho-education, physical exercise and treatment as usual

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Design and methods for a pilot randomized clinical trial involving exercise and behavioral activation to treat comorbid type 2 diabetes and major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Standards of medical care in diabetes--2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Psychotherapy for depression among incurable cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

The prevalence of co-morbid depression in adults with Type 2 diabetes: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

The prevalence of comorbid depression in adults with diabetes: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

The prevalence of co-morbid depression in adults with Type 1 diabetes: systematic literature review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Psychiatric and somatic comorbidities are negatively associated with quality of life in physically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Mental disorders in patients with obesity in comparison with healthy probands

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

The impact of clinical significance criteria on subthreshold depression prevalence rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Adjustment disorder with depressed mood: a critique of its DSM-IV and ICD-10 conceptualisations and recommendations for the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

It is time to adjust the adjustment disorder category

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

High agreement of self-report and physician-diagnosed somatic conditions yields limited bias in examining mental-physical comorbidity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

A clinical significance criterion is essential for diagnosing subthreshold depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

A second thought on subtyping major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Quality of life in medically ill persons with comorbid mental disorders: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Psychological and pharmacological interventions for depression in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Inappropriate prescriptions of antidepressant drugs in patients with subthreshold to mild depression: time for the evidence to become practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Collaborative care for depression in medically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Meta-review of depressive subtyping models

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Is the antidepressive effect of second-generation antidepressants a myth?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

21 January 2018

Depression and Diabetes

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

A Coefficient of Agreement for Nominal Scales

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Psychotherapy for depression in adults: A meta-analysis of comparative outcome studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Are Psychological and Pharmacologic Interventions Equally Effective in the Treatment of Adult Depressive Disorders?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

The effects of psychotherapy for adult depression are overestimated: a meta-analysis of study quality and effect size

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Relative efficacy of psychotherapy and combined therapy in the treatment of depression: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

New Onset Depression Following Myocardial Infarction Predicts Cardiac Mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Effect of depression on self-management behaviors and health outcomes in adults with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Antidepressant drug effects and depression severity: a patient-level meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Onset of major depression associated with acute coronary syndromes: relationship of onset, major depressive disorder history, and episode severity to sertraline benefit

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Depression, self-care, and medication adherence in type 2 diabetes: relationships across the full range of symptom severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Interventions for treating depression after stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Quantifying heterogeneity in a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Health care utilisation and quality of life in individuals with diabetes and comorbid mental disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Healthcare costs in patients with diabetes mellitus and comorbid mental disorders--a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Increased 12-month prevalence rates of mental disorders in patients with chronic somatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

The association of comorbid depression with mortality in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Subtyping major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Mental disorders among persons with diabetes--results from the World Mental Health Surveys

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Depression and poor glycemic control: a meta-analytic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Treatment of depression in diabetes: impact on mood and medical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Recent advances in understanding depression in adults with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

A review of treating depression in diabetes: emerging findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Depression and type 2 diabetes over the lifespan: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

The selection and design of control conditions for randomized controlled trials of psychological interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Active placebos versus antidepressants for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Type 2 diabetes mellitus as a risk factor for the onset of depression: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Mental disorders among persons with heart disease - results from World Mental Health surveys

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Bidirectional association between depression and type 2 diabetes mellitus in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Increased mortality risk in women with depression and diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Timing is everything: the onset of depression and acute coronary syndrome outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Efficacy and effectiveness of antidepressants: current status of research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

The interaction of depression and diabetes: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Antidepressants for depression in physically ill people

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Increased risk of myocardial infarction in depressed patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Mental disorders among adults with asthma: results from the World Mental Health Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Collaborative care management of late-life depression in the primary care setting: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Effect of interventions for major depressive disorder and significant depressive symptoms in patients with diabetes mellitus: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Does the DSM-IV clinical significance criterion for major depression reduce false positives? Evidence from the National Comorbidity Survey Replication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

Cost-effectiveness of systematic depression treatment among people with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

7 January 2021

The course of major depression in diabetes

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

7 January 2021

Predicting response to cognitive behavior therapy of depression in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

7 January 2021

Association of depression and diabetes complications: a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

7 January 2021

The association of patient relationship style and outcomes in collaborative care treatment for depression in patients with diabetes

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

7 January 2021

Psychotherapy intervention to reduce depressive symptoms in patients with diabetic foot syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

7 January 2021

Prevention of Major Depression in Complex Medically Ill Patients: Preliminary Results From a Randomized, Controlled Trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

7 January 2021

Fluoxetine for depression in diabetes: a randomized double-blind placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

7 January 2021

Comorbid depression is associated with increased health care use and expenditures in individuals with diabetes

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

7 January 2021

Cost-effectiveness and net benefit of enhanced treatment of depression for older adults with diabetes and depression

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

7 January 2021

Cognitive behavior therapy for depression in type 2 diabetes mellitus. A randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008381.PUB2

7 January 2021

10.1002/14651858.CD008381.PUB2

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

594552

594552

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference